SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_03 - A non-invasive lipidomic test accurately discriminates NASH from steatosis: a blind validation study | Dr. T. MontgomeryView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Microbiome: diagnostic considerations | Patrick GillevetView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Dynamic measurement of physiologic functions: any role in NASH diagnostics | Stephen Previs, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Biomarker development in pediatric NAFLD: special challenges in a special population | Saul Karpen, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Simple laboratory based indices | Ray Kim, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Potential approach to identify the NAFLD patient who will develop HCC | Yujin Hoshida, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Lipid and Bile acids as NAFLD-related biomarkers | Puneet Puri, MBBS, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Study Design and endpoints in Omics-based biomarker studies | Stephen Williams, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Proteomics-based biomarker discovery in NAFLD | Naga Chalasani, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Biomarkers: what can be learned from type 2 diabetes | Manu Chakravarthy, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_02 - Performance of non-invasive tests in the staging of fibrosis in patients with NAFLD: interim results of a prospective multicentre study | Dr. P. EddowesView Slideset
ASArun SanyalMD, MBBSSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Defining the gold standard in Biomarker Validation in NAFLD | Arun Sanyal, MD, MBBSView Slideset
